Literature DB >> 4926952

Vitamin C and the common cold.

C W Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4926952      PMCID: PMC1795409          DOI: 10.1136/bmj.1.5750.669

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Trial of ascorbic acid in prevention of colds.

Authors:  G H Walker; M L Bynoe; D A Tyrrell
Journal:  Br Med J       Date:  1967-03-11

2.  The administration of large doses of ascorbic acid in the prevention and treatment of the common cold. II.

Authors:  E Regnier
Journal:  Rev Allergy       Date:  1968-10

3.  The administration of large doses of ascorbic acid in the prevention and treatment of the common cold. I.

Authors:  E Regnier
Journal:  Rev Allergy       Date:  1968-09

4.  The origin of ascorbic acid stored in the leucocytes.

Authors:  H S Loh; C W Wilson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

5.  The growth maintaining activity and intestinal absorption of ascorbic acid in guinea-pigs.

Authors:  A Odumosu; C W Wilson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

6.  The relationsjhip between ascorbic acid concentrations and cortisol production during the development of scurvey in the guinea-pig.

Authors:  A Odumosu; C W Wilson
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

7.  The relationship between leucocyte ascorbic acid and plasma iron.

Authors:  H S Loh; C W Wilson
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

8.  Relationship of human ascorbic-acid metabolism to ovulation.

Authors:  H S Loh; C W Wilson
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

  8 in total
  2 in total

1.  Common cold symptomatology and vitamin C.

Authors:  C W Wilson; H S Loh; F G Foster
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

2.  Vitamin C metabolism and the common cold.

Authors:  C W Wilson; H S Loh
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.